LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10077-1 | QL-XII-47 | LSM-6019 |  | 71748056 | |
| 10040-1 | R406 | LSM-1040 |  | 11213558 | |
| 10480-1 | Radicicol | Monorden | LSM-43318 |  | 6323491 |
| 10138-1 | Ruxolitinib | LSM-1139 |  | 25126798 | |
| 10032-1 | Saracatinib | AZD0530 | LSM-1032 |  | 10302451 |
| 10046-1 | SB590885 | LSM-42746 |  | 53239990 | |
| 10001-1 | Seliciclib | (R)-Roscovitine; CYC202 | LSM-1001 |  | 160355 |
| 10056-1 | Selumetinib | AZD6244; Array142886 | LSM-1056 |  | 10127622 |
| 10035-1 | Sigma A6730 | KIN001-102; AKT inhibitor VIII; Akt1/2 kinase inhibitor | LSM-1035 |  | 10196499 |
| 10052-1 | Sirolimus | Rapamycin | LSM-1052 |  | 5040 |
| 10132-1 | SNS-032 | BMS-387032 | LSM-1132 |  | 3025986 |
| 10008-1 | Sorafenib | BAY-439006 | LSM-1008 |  | 216239 |
| 10119-1 | SU11274 | PKI-SU11274 | LSM-42791 |  | 53396327 |
| 10171-1 | TGX221 | LSM-1172 |  | 9907093 | |
| 10079-1 | Torin1 | LSM-1079 |  | 49836027 | |
| 10080-1 | Torin2 | LSM-1080 |  | 51358113 | |
| 10021-1 | Tozasertib | VX680; MK-0457 | LSM-1021 |  | 5494449 |
| 10142-1 | Trametinib | GSK-1120212; GSK1120212; GSK1120212B; JTP-74057 | LSM-1143 |  | 11707110 |
| 10111-1 | TWS119 | LSM-1111 |  | 9549289 | |
| 10068-1 | Vemurafenib | PLX4032; RG7204; R7204; RO5185426 | LSM-1068 |  | 42611257 |
| 10039-1 | WH-4-025 | LSM-44937 | |||
| 10481-1 | Withaferin A | NSC 273757; NSC-101088 | LSM-6685 |  | 265237 |
| 10064-1 | WYE-125132 | LSM-1064 |  | 25260757 | |
| 10084-1 | WZ3105 | LSM-5970 |  | 42628507 | |
| 10082-1 | WZ-4-145 | LSM-5545 |  |